Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Molndal – page 34

466 clinical trials in Molndal, Sweden across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Molndal at a glance
466
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

466 trials in Molndal

Open in trial search

Study of RBD4059 and acetylsalicylic acid in patients with stable coronary artery disease: evaluation of safety and drug behavior in the body

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Ribocure Pharmaceuticals AB
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Sodium Butyrate
  • Sponsor:Vastra Gotalandsregionen

Study of Sotorasib Treatment for First-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Sotorasib
  • Sponsor:Amgen Inc.

Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Amgen Inc.

Breast cancer

Not recruiting

Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:BeOne Medicines AG

Study on Ticagrelor for Patients with Heart Attack After Coronary Stenting

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ticagrelor
  • Sponsor:Vastra Gotalandsregionen

Cardiac failure

Not recruiting

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB

Cystic fibrosis

Not recruiting

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Deutivacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Tofacitinib
  • Sponsor:Pfizer Inc.

Infertility

Not recruiting

Study on Vaginal Progesterone for Improving Live Birth Rates in Women with Infertility Undergoing Frozen/Thawed IVF Natural Cycles

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Progesterone
  • Sponsor:Vastra Gotalandsregionen

Renal cell carcinoma

Not recruiting

Study of Belzutifan and Palbociclib for Patients with Advanced Renal Cell Carcinoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Molndal

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on heart failure prevention and treatment, including studies of new combination therapies with medications like baxdrostat and dapagliflozin. Research extends to coronary artery disease and stroke prevention in patients with atrial fibrillation.

  • Heart Failure Management
  • Stroke Prevention
  • Coronary Disease Treatment
02 Neurological Studies

Groundbreaking research in Alzheimer's disease treatment, investigating new compounds for early-stage intervention. Studies aim to improve cognitive function and evaluate novel therapeutic approaches for mild cognitive impairment.

  • Early Alzheimer's Treatment
  • Cognitive Function Assessment
  • Disease Progression Monitoring
03 Dermatological Research

Advanced trials examining treatments for atopic dermatitis and alopecia areata, testing new biological therapies and investigating long-term treatment efficacy and safety profiles.

  • Moderate-to-Severe Atopic Dermatitis
  • Alopecia Treatment
  • Skin Disease Management
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.